GoKawiil
Tech News
Henri Kagan and KensÅ Soai received the 2026 Nobel Prize in Chemistry for their work on the origins and control of molecular chirality, which is crucial for drug development and material synthesis. Their research sheds light on why living organisms predominantly use one enantiomer over the other, a phenomenon known as homochirality, and offers new methods to manipulate these reactions in laboratories.
Workers at Sama Pharmaceuticals near Nablus describe commutes that once took minutes now taking hours due to Israeli military checkpoints, with delays across Nablus averaging nearly two hours after October 2023. Employees like Ali Haj Ali and Ohood Khatatbeh describe unpredictable waits, sometimes turning back without reaching home, and towns like Beit Furik devising their own systems to manage a single checkpoint gate.
Enveda, a biotech startup using AI to identify drugs from plants and microbes, closed a $311 million Series E funding round at a $2 billion valuation. Catalio Capital Management led the round, with Iconiq and other investors participating. The valuation doubles what the company achieved a year earlier.
Researchers at Collaborations Pharmaceuticals found their AI drug-discovery tool could generate 40,000 potentially toxic chemical warfare molecules in under six hours, some more lethal than known nerve agents. The finding, first reported in 2022, is now cited by biosecurity experts as evidence that AI systems and increasingly accessible gene-editing tools could lower the barrier to creating dangerous biological or chemical agents.